Greg Meyers, EVP and Chief Digital and Technology Officer at Bristol Myers Squibb (or BMS), joins a16z Bio + Health general partner Jorge Conde.
Together, they talk about how AI could transform drug discovery and development at a large biopharma company—and how a company might have to adapt to harness AI; modalities they’re excited about; and Greg’s do’s and don’ts for startups looking to partner with a company like BMS.
Journal Club: Restoring a Reflex
Sea Turtle Medicine
Journal Club: Assembling an Egg
The Art and Science of Biology's Future
Journal Club: Engineering Living Materials
Value Versus Volume (in Healthcare)
Things That Make You Go Hmmmm in Healthcare
Journal Club: My Tick Teacher
May I Have Your Insurance Card Again, Please?
Journal Club: Suppressing Superbugs
From Junk DNA to an RNA Revolution
Journal Club: Slaying the Sleeper Cells of Aging
The Fundamental Principles of Reality
Journal Club: A Safer Psychedelic
The Genetics of Risk
Journal Club: Synthetic Germs, Our Newest Weapon for Fighting Cancer
The Biology of Brain Organoids (or, Don't Call it a Brain in a Dish!)
Journal Club: Why do only some people get severe COVID-19?
So You Wanna Build a Software Company in Healthcare?
The Machine That Made the Vaccine
Create your
podcast in
minutes
It is Free